Halozyme prices upsized $1.3B 1.50% converts due 2033

Halozyme priced $1.3B of 1.50% convertible senior notes due 2033, upsized from $1.05B. The initial conversion price was $139.84, with capped calls to $208.39. Net proceeds were about $1.275B.